dentalcorp Holdings (DNTL) AI Stock Analysis

• Market Cap: C$1.64B
• Dividend Yield: 0.6%
• Average Volume (3M): 143.78K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.70
• Revenue Growth: 9.94%
• EPS Growth: 35.48%
• Country: CA
• Employees: 10,200
• Sector: Healthcare
• Sector Strength: 51
• Industry: Medical - Care Facilities
• EPS (TTM): 0.15
• Shares Outstanding: 190,862,720
• 10 Day Avg. Volume: 127,955
• 30 Day Avg. Volume: 143,777
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: C$12.63
• Price Target Upside: 52.72% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 4

• Rating: 55 Neutral
• Price Target: C$8.50 ▲(2.78% Upside)

dentalcorp Holdings shows potential with steady revenue growth and positive cash flow, but faces significant challenges in profitability, reflected in its negative P/E ratio and low valuation score. Technical indicators suggest a lack of strong momentum, contributing to a moderate overall stock score.

Positive Factors

Mergers and Acquisitions

Strong free cash flow generation supports mergers and acquisitions as well as debt reduction, showcasing the strength of the business.

Revenue Growth

Management is confident in achieving 3-5% same-store revenue growth and expects margin expansion of 25-35 basis points annually, driven by operating leverage.

U.S. Market Expansion

Potential expansion into the U.S. market offers an opportunity for higher returns on invested capital, adding to the company's growth potential.

Negative Factors

Integration Challenges

Acquiring 12 practices could present integration challenges, potentially impacting expected contributions to adjusted EBITDA.

Market Expansion Risks

The company's expansion beyond Canada involves risks associated with entering new markets.

dentalcorp Holdings Business Overview & Revenue Model

Company Description

dentalcorp Holdings Ltd., through its subsidiaries, acquires and partners with dental practices to provide health care services in Canada. As of December 31, 2021, it owned and operated a network of approximately 458 dental practices supported by approximately 7,400 team members, including 1,400 dentists, 1,700 hygienists, and 4,100 auxiliary dental health professionals. The company was formerly known as Dentalcorp Overbite Ltd. dentalcorp Holdings Ltd. was founded in 2011 and is headquartered in Toronto, Canada.

How the Company Makes Money

Dentalcorp Holdings generates revenue primarily through the acquisition and management of dental practices. The company earns money by partnering with dental clinics, where it acquires a stake in the practice and provides operational support to improve efficiency and profitability. Revenue is generated from dental services provided at these practices, including routine check-ups, orthodontics, and specialized dental procedures. Additionally, Dentalcorp benefits from economies of scale, centralized procurement, and marketing, which enhance the financial performance of its partner practices. The company may also engage in partnerships with dental supply companies and other healthcare providers to further optimize its operations and expand its service offerings.

dentalcorp Holdings Financial Statement Overview

Summary

Dentalcorp Holdings shows revenue growth and operational efficiency, but persistent net losses impact overall financial health. The balance sheet is stable with manageable leverage, and cash flows are robust, supporting operational needs despite profitability issues.

Income Statement

The income statement reflects improving revenue growth, with a 2.40% increase from the previous year and a strong 25% rise from the year before. Gross profit margin stands at 46.3% TTM, showing efficiency in core operations. However, consistent net losses indicate challenges in overall profitability, with the net profit margin at -3.7%. EBITDA margin of 14.1% TTM suggests reasonable operational profitability before accounting for non-operating expenses.

Balance Sheet

The balance sheet displays a stable equity base with a decent equity ratio of 51.8% TTM. The debt-to-equity ratio is 0.78, indicating manageable leverage, which is crucial for financial stability. Return on equity is negative due to net losses, highlighting a need for improved profitability to enhance shareholder returns.

Cash Flow

Cash flow analysis shows solid operating cash flow, with a free cash flow to net income ratio of -2.6, which is a concern due to net losses. However, free cash flow showed a minor decline of 0.4% from the previous year, indicating resilience in cash generation despite profitability challenges. The operating cash flow to net income ratio of -3.45 reflects strong cash generation relative to net losses.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.62B	1.55B	1.43B	1.25B	1.03B	666.20M
Gross Profit	809.20M	772.70M	493.70M	611.90M	495.40M	321.60M
EBITDA	234.80M	222.20M	197.40M	183.40M	75.10M	99.70M
Net Income	-45.10M	-59.40M	-85.60M	-16.60M	-160.40M	-157.10M
Balance Sheet
Total Assets	3.43B	3.38B	3.29B	3.38B	2.84B	2.57B
Cash, Cash Equivalents and Short-Term Investments	77.70M	79.50M	39.00M	110.50M	141.80M	101.50M
Total Debt	1.39B	1.37B	1.35B	1.37B	1.15B	1.65B
Total Liabilities	1.66B	1.61B	1.55B	1.59B	1.32B	1.99B
Stockholders Equity	1.77B	1.77B	1.74B	1.79B	1.51B	584.00M
Cash Flow
Free Cash Flow	167.30M	147.10M	123.80M	106.00M	36.80M	-52.40M
Operating Cash Flow	220.20M	194.20M	153.40M	138.60M	55.10M	-35.20M
Investing Cash Flow	-228.00M	-170.80M	-172.10M	-419.80M	-262.90M	-151.30M
Financing Cash Flow	13.20M	16.50M	-52.30M	247.50M	248.10M	202.60M

dentalcorp Holdings Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 8.27
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:DNTL, the sentiment is Positive. The current price of 8.27 is above the 20-day moving average (MA) of 8.13, above the 50-day MA of 8.15, and above the 200-day MA of 8.15, indicating a bullish trend. The MACD of 0.03 indicates Negative momentum. The RSI at 57.45 is Neutral, neither overbought nor oversold. The STOCH value of 91.38 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:DNTL.

dentalcorp Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
EXE	70 Outperform	C$1.10B	13.30	65.09%	3.84%	8.68%	39.93%
SIA	59 Neutral	C$1.66B	45.16	6.94%	5.12%	10.13%	1.30%
DNTL	55 Neutral	C$1.64B	―	-2.58%	0.60%	9.94%	35.48%
CRRX	53 Neutral	C$185.47M	―	-2.17%	―	-0.16%	75.25%
Sector *	51 Neutral	$7.93B	-0.32	-43.43%	2.21%	22.30%	-1.88%
MFCSF	―	$201.73M	2.16	41.13%	2.37%	―	―
WELL	46 Neutral	C$1.20B	30.45	-14.61%	―	20.36%	-186.10%

dentalcorp Holdings Corporate Events

Dentalcorp Holdings Reports Strong Q2 2025 Financial Results and Expansion

Dentalcorp Holdings reported strong financial results for the second quarter of 2025, with revenue increasing by 8.9% to $435.2 million and Adjusted EBITDA growing by 9.9% to $81.2 million compared to the same period in 2024. The company also expanded its national presence by acquiring eight new practice locations, contributing to a record Adjusted Free Cash Flow of $45.6 million and a decrease in net debt ratio, indicating robust operational performance and strategic growth.

The most recent analyst rating on (TSE:DNTL) stock is a Buy with a C$13.00 price target. To see the full list of analyst forecasts on dentalcorp Holdings stock, see the TSE:DNTL Stock Forecast page.

Dentalcorp to Present at Key Investor Conferences in September 2025

Dentalcorp Holdings Ltd., a leading network of dental practices in Canada and North America, announced its participation in several upcoming investor conferences in September 2025. These events, including the Morgan Stanley Global Healthcare Conference and the Jefferies Healthcare Services Conference, provide an opportunity for Dentalcorp to showcase its growth and strategic initiatives, potentially enhancing its industry positioning and stakeholder engagement.

The most recent analyst rating on (TSE:DNTL) stock is a Buy with a C$11.00 price target. To see the full list of analyst forecasts on dentalcorp Holdings stock, see the TSE:DNTL Stock Forecast page.

Dentalcorp Declares Dividend and Schedules Q2 2025 Results Release

Dentalcorp Holdings Ltd., a leading network of dental practices in Canada and North America, has declared a dividend of $0.025 per share, payable on July 22, 2025, to shareholders of record as of July 3, 2025. The company also announced that it will release its second-quarter 2025 financial results on August 8, 2025, followed by a conference call to provide a business update, which may influence stakeholder perceptions and market positioning.

The most recent analyst rating on (TSE:DNTL) stock is a Buy with a C$11.00 price target. To see the full list of analyst forecasts on dentalcorp Holdings stock, see the TSE:DNTL Stock Forecast page.

Dentalcorp to Engage with Investors at Key Conferences

Dentalcorp Holdings Ltd., a leading network of dental practices in Canada and North America, announced its participation in upcoming investor conferences, including the Jefferies Global Healthcare Conference and Canaccord Genuity’s Annual Growth Conference. This participation underscores Dentalcorp’s commitment to engaging with investors and stakeholders, potentially enhancing its industry positioning and growth prospects.

The most recent analyst rating on (TSE:DNTL) stock is a Buy with a C$11.00 price target. To see the full list of analyst forecasts on dentalcorp Holdings stock, see the TSE:DNTL Stock Forecast page.

Dentalcorp Announces AGM Voting Results and Strategic Amendments

Dentalcorp Holdings announced the results of its Annual General and Special Meeting of Shareholders, where all nominated directors were elected, Ernst & Young LLP was re-appointed as auditors, and amendments to the company’s Equity Incentive Plan, Legacy Option Plan, and Deferred Share Unit were approved. These decisions reflect the company’s strategic focus on strengthening its governance and operational framework, potentially enhancing its position in the dental industry and providing growth opportunities for stakeholders.

The most recent analyst rating on (TSE:DNTL) stock is a Buy with a C$11.00 price target. To see the full list of analyst forecasts on dentalcorp Holdings stock, see the TSE:DNTL Stock Forecast page.